Exploring the Potential Role of Antineuronal Autoantibodies in Cognitive Performance in Patients with High-Grade Glioma Undergoing Radiation
Molecules · 20.11.2026 · 31 (22) · 4217
DOI: 10.3390/molecules31224217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 20.11.2026. Verfasst von Małgorzata Dudzic und 7 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland.
Abstract (Originalsprache)
Cognitive impairment is common in patients with high-grade glioma (HGG), and its underlying mechanisms are complex and multifactorial. The potential role of autoimmune mechanisms in cognition has been investigated in patients with extracranial malignancies. However, their relevance to cognitive outcomes in HGG patients remains insufficiently explored. This prospective longitudinal study investigated whether antineuronal antibody (ANAb) status was associated with cognitive performance in 44 adults with HGG undergoing radiotherapy. Participants were grouped as Central (n = 15), Peripheral (n = 9), or Ab-negative (n = 20). Cognitive function was assessed at four time points using Addenbrooke’s Cognitive Examination III (ACEIII), Color Trails Test (CTT), and Digit Span. Age- and education-adjusted linear mixed-effects models assessed cognitive performance from baseline to three months post-radiotherapy; six-month results were analyzed descriptively. No significant differences in cognitive trajectories were identified across groups. However, exploratory contrasts suggested greater declines in memory and language in the Central group, and in global cognition, visuospatial performance, CTT-2, and language in the Peripheral group, compared with the Ab-negative group. These findings suggest possible domain-specific differences but do not establish an association between ANAb status and cognitive decline. Small groups, antibody heterogeneity, and incomplete follow-up warrant cautious interpretation and further investigation.
Förderung
- National Science Centre, Poland
Zitieren
APA
Dudzic, M., Pieczyńska, A., Adamska, K., Michalak, S., Osztynowicz, K., Pilarska, A., Procyk, D., & Hojan, K. (2026). Exploring the Potential Role of Antineuronal Autoantibodies in Cognitive Performance in Patients with High-Grade Glioma Undergoing Radiation. Molecules, 31(22), 4217. https://doi.org/10.3390/molecules31224217
Vancouver
Dudzic M, Pieczyńska A, Adamska K, Michalak S, Osztynowicz K, Pilarska A, et al. Exploring the Potential Role of Antineuronal Autoantibodies in Cognitive Performance in Patients with High-Grade Glioma Undergoing Radiation. Molecules. 2026;31(22):4217. doi:10.3390/molecules31224217
BibTeX
@article{Dudzic2026,
author = {Dudzic, Małgorzata and Pieczyńska, Anna and Adamska, Krystyna and Michalak, Sławomir and Osztynowicz, Krystyna and Pilarska, Agnieszka and Procyk, Danuta and Hojan, Katarzyna},
title = {Exploring the Potential Role of Antineuronal Autoantibodies in Cognitive Performance in Patients with High-Grade Glioma Undergoing Radiation},
journal = {Molecules},
year = {2026},
volume = {31},
number = {22},
pages = {4217},
doi = {10.3390/molecules31224217}
}
EUVIMED